US Patent Issued to Cedars-Sinai Medical Center on Aug. 18 for "Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease" (California Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,611, issued on Aug. 18, was assigned to Cedars-Sinai Medical Center (Los Angeles).

"Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease" was invented by Alexander Laperle (North Hollywood, Calif.), Samuel Sances (Santa Monica, Calif.), Nur Yucer (Los Angeles) and Clive N. Svendsen (Pacific Palisades, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Induced Pluripotent Stem Cell (Ipsc) technology enables the generation and study of living brain tissue relevant to Parkinson's disease (PD) ex vivo. Utilizing cell lines from PD patients presents a powerful discovery system that links cellular phenotype...